Vor Biopharma: Targeted Therapies For Transplants
Steven Puetzer/The Image Bank via Getty Images
Source: Company
Summary
Vor Biopharma (VOR) is an early-stage cell therapy company that engineers hematopoietic stem cells (“HSC”) to replace the standard-of-care in transplants. With a similar thesis as…
